215 related articles for article (PubMed ID: 19946591)
1. Human herpes virus 8 replication during disseminated tuberculosis in a man with human immunodeficiency virus: a case report.
Inoubli S; Toutous-Trellu L; Cathomas G; Oksenhendler E; Hirschel B; El Amari EB
J Med Case Rep; 2009 Nov; 3():113. PubMed ID: 19946591
[TBL] [Abstract][Full Text] [Related]
2. HHV-8 Linked to Kaposi's Sarcoma and Castleman's Disease in HIV-1-infected patient: Case Report and Review of the Literature.
Zaghdoudi A; Harrabi H; Tiouiri Benaissa H
Int J Hematol Oncol Stem Cell Res; 2024 Apr; 18(2):202-205. PubMed ID: 38868814
[TBL] [Abstract][Full Text] [Related]
3. Human Herpes Virus-8-Associated Multicentric Castleman's Disease in a Human Immunodeficiency Virus-Positive Patient with a Previous History of Kaposi's Sarcoma.
Huang G; Low G
J Clin Imaging Sci; 2015; 5():59. PubMed ID: 26664776
[TBL] [Abstract][Full Text] [Related]
4. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
[TBL] [Abstract][Full Text] [Related]
5. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?
O'Leary J; Kennedy M; Howells D; Silva I; Uhlmann V; Luttich K; Biddolph S; Lucas S; Russell J; Bermingham N; O'Donovan M; Ring M; Kenny C; Sweeney M; Sheils O; Martin C; Picton S; Gatter K
Mol Pathol; 2000 Apr; 53(2):69-76. PubMed ID: 10889905
[TBL] [Abstract][Full Text] [Related]
6. Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.
Yaghoobi R; Pazyar N; Tavakoli S
Indian J Dermatol; 2015; 60(3):323. PubMed ID: 26120185
[TBL] [Abstract][Full Text] [Related]
7. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.
Bollen J; Polstra A; Van Der Kuyl A; Weel J; Noorduyn L; Van Oers M; Cornelissen M
BMC Blood Disord; 2003 Dec; 3(1):3. PubMed ID: 14670091
[TBL] [Abstract][Full Text] [Related]
8. Human herpesvirus-8 in lymphomatous and nonlymphomatous body cavity effusions developing in Kaposi's sarcoma and multicentric Castleman's disease.
Ascoli V; Sirianni MC; Mezzaroma I; Mastroianni CM; Vullo V; Andreoni M; Narciso P; Scalzo CC; Nardi F; Pistilli A; Lo Coco F
Ann Diagn Pathol; 1999 Dec; 3(6):357-63. PubMed ID: 10594287
[TBL] [Abstract][Full Text] [Related]
9. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
10. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
11. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.
Ortega L; Cooper CJ; Otoukesh S; Mojtahedzadeh M; Didia CS; Torabi A; Nahleh Z
Rare Tumors; 2014 Jul; 6(3):5480. PubMed ID: 25276327
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus-negative multicentric Castleman's disease coexistent with Kaposi's sarcoma on
Hwang JP; Kim J; Park JM
Mol Clin Oncol; 2019 Feb; 10(2):318-320. PubMed ID: 30680214
[TBL] [Abstract][Full Text] [Related]
13. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
14. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
15. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports.
Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P
J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
17. Imaging features of multicentric Castleman's disease in HIV infection.
Hillier JC; Shaw P; Miller RF; Cartledge JD; Nelson M; Bower M; Francis N; Padley SP
Clin Radiol; 2004 Jul; 59(7):596-601. PubMed ID: 15208065
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated multicentric Castleman's disease.
Naime Fde F; Fakhouri F; Martins CS; Couto WJ
Rare Tumors; 2012 Jun; 4(3):e40. PubMed ID: 23087796
[TBL] [Abstract][Full Text] [Related]
19. Multicentric Castleman's disease masquerading as HIV-related lymphoma.
Dayyani F; Pantanowitz L; Sandridge TG; Sullivan RJ; Dezube BJ
Am J Med Sci; 2007 Oct; 334(4):317-9. PubMed ID: 18030193
[TBL] [Abstract][Full Text] [Related]
20. Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman's disease in an HIV-positive patient.
Osa M; Maeda T; Misawa K; Imai K; Fujikura Y; Kawana A
J Infect Chemother; 2016 Dec; 22(12):804-807. PubMed ID: 27373909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
